EFFECTS OF HYPERTONIC MANNITOL ON CONTRACTILE RESPONSES AND CA-45 MOVEMENTS IN ISOLATED CANINE ARTERIES

被引:7
作者
GOODMAN, FR
WILLERSON, JT
HESTER, RK
WEISS, GB
机构
[1] UNIV TEXAS, HLTH SCI CTR,SW MED SCH,HLTH SCI CTR, ISCHEMIC HEART CTR, DALLAS, TX 75235 USA
[2] UNIV TEXAS, HLTH SCI CTR,SW MED SCH,HLTH SCI CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA
[3] UNIV TEXAS, HLTH SCI CTR,SW MED SCH,HLTH SCI CTR, DEPT INTERNAL MED,CARDIAC UNIT, DALLAS, TX 75235 USA
关键词
Calcium fluxes; Canine arteries; Mannitol; Vasodilators;
D O I
10.1097/00005344-197903000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Summary: The effects of hyperosmotic mannitol on vascular smooth muscle contractile responses and on 45Ca movements were examined in different isolated canine arteries. Prior exposure to 50 dim mannitol decreased contractile responses elicited with dopamine (DA) in helical strips of canine terminal mesenteric arteries (Tm) and decreased the contractile response elicited with potassium (K+) in both isolated left anterior descending (LAD) and circumflex coronary arteries. Tension responses induced by norepinephrine or DA in the Tm and K+ and prostaglandin F2α in LAD were relaxed by subsequent exposure to mannitol. Mannitol increased the uptake of 45Ca in Tm arteries. Exposure of the Tm and branches of the LAD to mannitol during the washout of 45Ca resulted in a decrease in the rate of loss of 45Ca; the presence of either K+, Mg2+, or ethylenediamine tetraacetic acid during the washout did not prevent the observed mannitol-induced decrease in 45Ca efflux. These effects of mannitol on 45Ca efflux without a concomitant major change in net 45Ca uptake could be attributed to an increase in bound Ca2+ at relevant membrane sites or stores. Thus, hypertonic mannitol may alter contractile responsiveness of selected canine arteries by impeding the release of bound and/or sequestered Ca2+ and, in this manner, decreasing the Ca2+ concentration at the contractile elements. © 1979 Raven Press, New York.
引用
收藏
页码:265 / 276
页数:12
相关论文
共 27 条
[1]  
ADAMS HR, 1975, J PHARMACOL EXP THER, V193, P393
[2]  
ALTURA BM, 1976, J PHARMACOL EXP THER, V197, P352
[3]  
BIANCHI CP, 1965, J PHARMACOL EXP THER, V147, P360
[4]   VASCULAR SMOOTH-MUSCLE UPDATED [J].
BOHR, DF .
CIRCULATION RESEARCH, 1973, 32 (06) :665-672
[5]  
BOHR DF, 1971, VASCULAR NEUROEFFECT, P72
[6]   SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].
FLECKENSTEIN, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166
[7]  
Fleckenstein A., 1976, IONIC ACTIONS VASCUL, P117
[8]  
FLECKENSTEIN A, 1976, CORONARY ANGIOGRAPHY, P297
[9]  
FLEISCH JH, 1974, BLOOD VESSELS, V11, P193
[10]  
FURCHGOTT R F, 1960, Methods Med Res, V8, P177